Dec'04 | Dec'05 | Dec'06 | Dec'07 | Dec'08 | Dec'09 | Dec'10 | Dec'11 | Dec'12 | Dec'13 | Dec'14 | Dec'15 | Dec'16 | Dec'17 | Dec'18 | Dec'19 | Dec'20 | Dec'21 | Dec'22 | Dec'23 | |
---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
Net Debt | $2,872.0M | $2,796.0M | $3,422.0M | $4,047.0M | ($1,526.0M) | ($2,153.0M) | ($1,856.0M) | ($3,242.0M) | $5,738.0M | $4,754.0M | $2,261.0M | $4,304.0M | $2,471.0M | $1,150.0M | ($1,535.0M) | $35.2B | $37.1B | $31.6B | $31.6B | $29.2B |
Discover the top 20 best undervalued stocks to buy for Jan 2025, listed on the Nasdaq or NYSE.
Discover the top 20 best undervalued large-cap growth stocks to buy for Jan 2025, listed on the Nasdaq or NYSE.
Discover the top 20 best undervalued high-yield dividend stock that offers both growth potential and attractive dividend returns for Jan 2025.
As of today, Bristol-Myers Squibb Company's last 12-month Net Debt is $43.3B, based on the financial report for Sep 30, 2024 (Q3 2024).
Over the last year, Bristol-Myers Squibb Company's Net Debt growth was 37.1%. The average annual Net Debt growth rates for Bristol-Myers Squibb Company have been 8.3% over the past three years, N/A over the past five years.
Over the last year, Bristol-Myers Squibb Company's Net Debt growth was 37.1%, which is higher than industry growth of 0.3%. It indicates that Bristol-Myers Squibb Company's Net Debt growth is Bad.